Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

B

BCYC

Bicycle Therapeutics plc

NASDAQHealthcareBiotechnologyGB

NASDAQ · Healthcare · Biotechnology · GB

$4.30

+1.42%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

BCYC: FY25 Deep Dive

Bicycle Therapeutics FY25 at $73M. NI $-219M; EPS $-3.16.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.